Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Correction

This article was originally published in The Tan Sheet

Executive Summary

A news brief in the Aug. 31, 2009, issue, "AdvoCare loses verdict to distributors," should have included a comment from an AdvoCare spokeswoman saying the company believes the Badgetts, its former distributors, were terminated appropriately and AdvoCare intends to appeal the jury verdict that went against the firm. "The Tan Sheet" regrets the omission and corrected the brief posted on our Web site (1"The Tan Sheet" Aug. 31, 2009, In Brief)

You may also be interested in...



AdvoCare loses verdict to distributors

The Carollton, Texas-based multi-level marketer of nutritional and skin-care products must pay $1.9 million to former distributors under a Dallas County court jury verdict finding AdvoCare violated Texas deceptive trade practices law. Dallas law firm Kilgore & Kilgore, counsel for plaintiffs Bruce and Teresa Badgett, said Aug. 26 that AdvoCare refused to change its marketing and business structures to "meet the accountability demands of" the Badgetts and then cancelled their distribution agreements. A spokeswoman said the Badgetts were terminated appropriately and AdvoCare intends to appeal the decision. Separately, the firm and competitive swimmer Jessica Hardy filed suit against each other after Hardy failed a performance-enhancing drug test and blamed an AdvoCare supplement (1"The Tan Sheet" Feb. 23, 2009)

Finance Watch: A SPACtacular Week For Biopharma Deals And Dollars

Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.

US FDA Gives Wholesalers But Not Manufacturers More Time To Begin Verifying Saleable Returns

Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.

Topics

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel